Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

31.42 -0.28 (-0.88%)
Streaming Delayed Price Updated: 12:56 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dimensional World ex U.S. Core Equity 2 ETF

< Previous 1 2 Next >
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure
Via Stocktwits
US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles
Via Stocktwits
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’
Via Stocktwits
Novo Nordisk Says New Obesity Treatment Achieved 11.8% Body Weight Reduction In Late-stage Study
Via Stocktwits
Stellantis Recalls Nearly 54,000 Vehicles In US Over Concerns Regarding Fuel Pump: But Retail Sees Stock Rallying To $10 This Week
Via Stocktwits
Topics Product Recall
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report
Via Stocktwits
Toyota Recalls Over Half A Million Vehicles In The US
Via Stocktwits
Topics Product Recall
Ford Supplier Magna International Appoints Former Timken Executive As CFO
Via Stocktwits
Topics Supply Chain
Stellantis Stock Slips After US Regulator Probes 287,000 Chrysler Minivans Over Concerns Regarding Electric Power Steer
Via Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More
Via Stocktwits
Citi Lowers Price Target On This Chinese EV Maker After Disappointing Q3 Guidance: Retail Expects Shares To ‘Eventually Implode’
Via Stocktwits
Li Auto Announces Lower Q3 Delivery Outlook Despite New Vehicle Launches: Retail Sees i8, i6 Selling Like ‘Hot Cakes’
Li Auto now expects vehicle deliveries to be between 90,000 and 95,000 vehicles, representing a year-over-year decrease of 41.1% to 37.8%. 
Via Stocktwits
Topics Earnings
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today?
Novo Nordisk has entered into a collaboration with Replicate BioScience under which it will receive a defined, exclusive, worldwide license to use the latter’s self-replicating RNA platform to develop... 
Via Stocktwits
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More
Via Stocktwits
Stellantis Shells Out $41M More To Expand Its U.S. Parts Distribution Network: More Details Inside
Via Stocktwits
OraSure Receives Warning From Ron Zwanziger: Entrepreneur Warns Of Adversarial Path If Board Continues To Refuse Buyout Offer
Zwanziger made an unsolicited all-cash offer for the company earlier in the summer but was rebuffed. 
Via Stocktwits
This Stock Just Got Downgraded By Macquarie On Rising Competition In Chinese Market – Do You Own It?
Via Stocktwits
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
Via Stocktwits
Toyota Warns Higher US Tariff Impact For FY26: Retail Sees No Reason To Cheer
Via Stocktwits
Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year
Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark. 
Via Stocktwits
AstraZeneca Launches Home Delivery Service For Its Self-Administrable Flu Vaccine
Flumist can be self-administered by adults 18 to 49 years of age or administered by a parent or caregiver to individuals 2-17 years of age. 
Via Stocktwits
Philips Plans $150M New Investments In US Manufacturing, R&D: Retail’s On The Fence
The investment includes the expansion of the company’s Reedsville, PA, site and the recently announced expansion of the Image Guided Therapy facility in Plymouth, MN, the company said. 
Via Stocktwits
Topics Economy Government
Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side
UBS downgraded Novo Nordisk to ‘Neutral’ from ‘Buy’ with a price target of DKK 340, down from DKK 600. 
Via Stocktwits
Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside
Kruger’s position was newly created, and he will report to CEO Antonio Filosa. 
Via Stocktwits
Topics World Trade
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
Via Stocktwits
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React
Via Stocktwits
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700. 
Via Stocktwits
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug
The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%. 
Via Stocktwits
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
A decision by the FDA on the new submission is expected in the first half of 2026. 
Via Stocktwits
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.